Radiopharmaceutical Supply – Tc-99m Tetrofosmin

The contract entails the supply of non-highly enriched uranium derived Tc-99m Tetrofosmin for use in cardiac imaging procedures, encompassing all necessary steps from preparation and calibration to quality control and timely delivery. The product must meet stringent regulatory and technical standards to ensure safety and efficacy in clinical settings, with particular emphasis on non-HEU sourcing to comply with nuclear material security and non-proliferation protocols. All phases of the process must be conducted under controlled conditions with documented traceability and adherence to current Good Manufacturing Practices. This is a subcontract issued by the Department of Veterans Affairs through the 255-NETWORK Contract Office 15, with a North American Industry Classification System code of 325412 indicating pharmaceutical manufacturing. The opportunity was posted on May 7, 2026, with responses required by May 15, 2026, at 12:00 PM. The place of performance and exact delivery location are not specified, but the service is intended to support VA medical facilities nationwide. The subcontractor must ensure reliable, consistent supply to maintain uninterrupted patient care, with no tolerance for delays or quality deviations.